ClinicalTrials.gov
public full text
Public Domain
Precision Medicine in the Prostate Cancer Care Pathway
This study aims to evaluate the use of a prostate cancer specific predisposition genetic panel test in men with / at high risk of prostate cancer. The genetic test will analyse men's DNA samples for the presence of mutations in rare genes as well as common genetic variation to provide men with information about their risk of prostate cancer. This study will evaluate the clinical impact of the test on risk assessment and clinical management in terms of screening and treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations#1308732
- Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer#1185228
- A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care#1436971
- Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation#1103237
- Prostate Cancer Genius App Education and Home-based PSA Screening for African American Men#840220
Record · ID 1443934
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive